After raising $62M, New Haven biotech Allyx Therapeutics advances experimental Alzheimer’s drug

On:
In: Business Watch
With: 0 Comments
After raising $62M, New Haven biotech Allyx Therapeutics advances experimental Alzheimer’s drug

Source: Hartford Business Journal

Indexed: Tue, 14 Jul 2026 16:34:03 UTC

Read original source →

Not a government entity. Not a broker or agent. Public information index only. Verify independently.

Bir yanıt yazın

E-posta adresiniz yayınlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir